Top what type of drug is nembutal Secrets

pentobarbital will lessen the extent or result of abiraterone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

pentobarbital will reduce the level or outcome of disopyramide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.

pentobarbital will minimize the extent or influence of capivasertib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Strong or reasonable CYP3A inducers reduce capivasertib exposure, which can minimize efficacy.

pentobarbital will lessen the extent or effect of docetaxel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.

pentobarbital will reduce the level or effect of fosamprenavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital will decrease the extent or outcome of pitolisant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Pitolisant publicity is lessened by fifty% if coadministered with potent CYP3A4 inducers.

pentobarbital will lower the level or impact of diazepam buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Strong or moderate CYP3A4 inducers may possibly raise more info price of diazepam elimination; consequently, efficacy of diazepam can be decreased.

pentobarbital and daridorexant both enhance sedation. Modify Therapy/Keep track of Intently. Coadministration will increase danger of CNS melancholy, which may result in additive impairment of psychomotor general performance and bring about daytime impairment.

pentobarbital will reduce the extent or result of quinidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

pentobarbital will minimize the level or effect of bosentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.

pentobarbital will lower the level or result of buprenorphine buccal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

pentobarbital will minimize the level or outcome of temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

Contraindicated (one)pentobarbital will lessen the extent or result of doravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

Contraindicated (1)pentobarbital will decrease the extent or result of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Prevent coadministration. Solid or reasonable CYP3A inducers might decrease cobimetinib systemic publicity by >80% and reduce its efficacy.